Prevacus
Tallahassee · Founded 2012
About Prevacus
Prevacus, Inc. is a drug development company working on prevention and treatment of mild traumatic brain injury (mTBI) or concussion. Every year 4-6 million people suffer from mTBIs many of which do not reach an emergency room and go unreported. Apart from analgesics for associated pain and anti-depressants, there are no approved pharmaceutical therapies for mTBI.
Company Facts
- Founded: 2012
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.7M
- Funding stage: Seed
- Last round: Seed (Feb 2013)
- Website: http://prevacus.com
- Phone: +1 850-544-2962
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/prevacus-3134737 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.